Elebsiran (+ Tobevibart) Investigational RNAi therapy licensed to Vir Biotechnology, in Phase 3 development with tobevibart for hepatitis D virus infection.
Visit productCosigns Received
Be the first Cosign
Put your name behind Elebsiran (+ Tobevibart).
Add it to your Products I use list and share why you use it.